Position in CYTK
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,052,846
+$848,450 QoQ
Shares Held
15,974
+329.5% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026INCEPTIONR LLC holds $19,867,167 across 35 Biotechnology names. CYTK ranks #6 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
44,557 | $2,137,399 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
30,726 | $1,735,711 | |
| 3 | INCY |
Incyte Corp
|
13,713 | $1,290,667 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
13,143 | $1,278,156 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
16,821 | $1,263,088 | |
| 6 | CYTK |
Cytokinetics Inc
This page
|
15,974 | $1,052,846 | |
| 7 | INSM |
INSMED Inc
|
5,172 | $845,725 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
11,923 | $770,583 |
All Filings in CYTK
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,052,846 | 15,974 | Shares | Sole | 2026-05-14 | |
| 2025-09-30 | $204,396 | 3,719 | Shares | Sole | 2025-11-13 | |
| 2025-03-31 | $379,112 | 9,433 | Shares | Sole | 2025-05-12 | |
| 2024-03-31 | $367,797 | 5,246 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $289,209 | 3,464 | Shares | Sole | 2024-02-08 | |
| No filing history on record for this holder in this stock. | ||||||